Supplemental Figure 1 . The anti-phospho-Ser122 antibody only recognizes Ace2 from cells that express Cbk1.
(B) Quantification of ratio of nuclear fluorescence vs. cytoplasmic fluorescence of (A). Cells treated with LMB exhibit higher levels of nuclear fluorescence than non-treated cells.
Supplemental Figure 3.
Pho85as inhibition occurs within 10 minutes of 1NA-PP1 treatment.
(A) Quantification of Pho4-GFP nuclear localization in pho85as-1 cells, with and without 10 minute treatment with 10 µM 1NA-PP1. Pho4-GFP localizes to 100% of nuclei when Pho85as kinase activity is inhibited.
(B) Micrographs of pho85as-1 Pho4-GFP cells 0 and 10 minutes after kinase inhibition. Figure 4 . Timecourse of Cdc14-reversible mobility shifting of Ace2-HA following M-phase arrest and release.
Supplemental
(A) Ace2-HA GAL-CDC20 were arrested in M phase and Ace2-HA was immunoprecipitated at 0, 20, 30, and 40 minutes following release from arrest. Immunoprecipitated Ace2 was mock treated (first lane in each set of three), Cdc14 treated, or lambda phosphatese treated (second and third lanes in each set of three). Material was immunoblotted with α-pS122 and anti-HA to visualze Ace2-HA mobility shifting. Note that Cdc14 did not remove serine 122 phosphorylation, confirming its specificity.
(B) Ace2-HA GAL-CDC20 cdc28-as1 pho85-as1 were arrested and released as in (A), with 1NA-PP1 and 1NM-PP1 added at the time of release. Ace2-HA was similarly immunoprecipitated, treated, and blotted. Note that significant Cdc14-reversible shifting occurs at 30 minutes post-release despite inhibition of both CDKs.
(C) As in (A) and (B), Ace2-AP-HA was immunoprecipitated from mitotically synchronized cells. It did not exhibit noticeable Cdc14-reversible shifting at any point in this timecourse. Figure 5 . Eliminating all Ace2 CDK phosphorylation sites does not compromise its function or asymmetry.
(A) Efficiency of cell separation scored by number cells grown in liquid culture associated in a group. Cells carrying the ace2-AP allele exhibited no separation defect.
(B) The asymmetric localization of ace2-AP-GFP was similar to that of wild type Ace2-GFP.
Supplemental Figure 6 . Ace2-AP-GFP localizes to all nuclei of pho85Δ cells when nuclear export is blocked.
Images of wild-type cells (left) or ace2-AP-GFP in pho85Δ crm1-T539 cells (right) after treatment with LMB. Cells labeled red are mothers and unlabeled cells are daughters. Note that ace2-AP-GFP is evident in nuclei at nearly all cell cycle stages. Scale bar, 2 µm. Figure 7 . CDK sites outside Ace2's NLS contribute to its G1 cytoplasmic retention.
Localization of ace2-AAA-GFP (T575A, S701A, S714A) was examined in G1 pho85∆ crm1-T539C daughter cells with and without LMB treatment. Mother and daughter cells were distinguished as in Figure 3A . Each bar denotes average of 3 independent trials with error bars denoting SEM. Ace2-AP-GFP localization in pho85∆ cells from Figure  4F is shown for comparison. Number of cells with nuclear GFP signal was statistically significantly higher for ace2-AP-GFP expressing cells (p = 0.021, two-tailed Student's T test).
